| STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ... Cancer discovery 8 (7), 822-835, 2018 | 1253 | 2018 |
| The epidemiology of lung cancer PM de Groot, CC Wu, BW Carter, RF Munden Translational lung cancer research 7 (3), 220, 2018 | 711 | 2018 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ... Nature medicine 27 (3), 504-514, 2021 | 442 | 2021 |
| Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer JP Robichaux, YY Elamin, Z Tan, BW Carter, S Zhang, S Liu, S Li, T Chen, ... Nature medicine 24 (5), 638-646, 2018 | 438 | 2018 |
| CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ... Cancer discovery 8 (9), 1156-1175, 2018 | 369 | 2018 |
| Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression EJ Aguilar, B Ricciuti, JF Gainor, KL Kehl, S Kravets, S Dahlberg, ... Annals of Oncology 30 (10), 1653-1659, 2019 | 269 | 2019 |
| Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. T Cascone, WN William, A Weissferdt, HY Lin, CH Leung, BW Carter, ... Journal of Clinical Oncology 37 (15_suppl), 8504-8504, 2019 | 203 | 2019 |
| Nivolumab and ipilimumab in metastatic uveal melanoma: results from a single-arm phase II study MS Pelster, SK Gruschkus, R Bassett, DS Gombos, M Shephard, ... Journal of Clinical Oncology 39 (6), 599, 2021 | 201 | 2021 |
| Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium RN Amaria, AM Menzies, EM Burton, RA Scolyer, MT Tetzlaff, ... The Lancet Oncology 20 (7), e378-e389, 2019 | 196 | 2019 |
| ITMIG classification of mediastinal compartments and multidisciplinary approach to mediastinal masses BW Carter, MF Benveniste, R Madan, MC Godoy, PM De Groot, ... Radiographics 37 (2), 413-436, 2017 | 188 | 2017 |
| Approaching the patient with an anterior mediastinal mass: a guide for clinicians BW Carter, EM Marom, FC Detterbeck Journal of Thoracic Oncology 9 (9), S102-S109, 2014 | 187 | 2014 |
| Approaching the patient with an anterior mediastinal mass: a guide for radiologists BW Carter, M Okumura, FC Detterbeck, EM Marom Journal of Thoracic Oncology 9 (9), S110-S118, 2014 | 141 | 2014 |
| A modern definition of mediastinal compartments BW Carter, N Tomiyama, FY Bhora, MLR De Christenson, J Nakajima, ... Journal of Thoracic Oncology 9 (9), S97-S101, 2014 | 138 | 2014 |
| Managing incidental findings on thoracic CT: mediastinal and cardiovascular findings. A white paper of the ACR incidental findings committee RF Munden, BW Carter, C Chiles, H MacMahon, WC Black, JP Ko, ... Journal of the American College of Radiology 15 (8), 1087-1096, 2018 | 132 | 2018 |
| Small cell lung carcinoma: staging, imaging, and treatment considerations BW Carter, BS Glisson, MT Truong, JJ Erasmus Radiographics 34 (6), 1707-1721, 2014 | 132 | 2014 |
| Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma A Reuben, CN Spencer, PA Prieto, V Gopalakrishnan, SM Reddy, ... NPJ genomic medicine 2 (1), 10, 2017 | 131 | 2017 |
| Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma LT Nickell Jr, JP Lichtenberger III, L Khorashadi, GF Abbott, BW Carter Radiographics 34 (6), 1692-1706, 2014 | 121 | 2014 |
| Phase II trial of concurrent atezolizumab with chemoradiation for unresectable NSCLC SH Lin, Y Lin, L Yao, N Kalhor, BW Carter, M Altan, G Blumenschein, ... Journal of Thoracic Oncology 15 (2), 248-257, 2020 | 118 | 2020 |
| OA02. 06 a phase II trial of poziotinib in EGFR and HER2 exon 20 mutant non-small cell lung cancer (NSCLC) J Heymach, M Negrao, J Robichaux, B Carter, A Patel, M Altan, ... Journal of Thoracic Oncology 13 (10), S323-S324, 2018 | 117 | 2018 |
| Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy H Menon, D Chen, R Ramapriyan, V Verma, HB Barsoumian, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 106 | 2019 |
